Search Results - "Fina, C."

Diagnostic imaging findings in a referral population of dogs diagnosed with immune‐mediated haemolytic anaemia: 50 cases (2015‐2018) by De Laet, N., Fina, C., Dhumeaux, M., Hrovat, A.

“…Objectives To describe and characterise changes documented on thoracic and abdominal imaging of dogs with confirmed immune‐mediated haemolytic anaemia…”
Get full text

Titanium mesh osteosynthesis for the treatment of severely comminuted maxillofacial fractures in four dogs by Vallefuoco, R., Bird, F., Gordo, I., Brissot, H., Fina, C.

“…Introduction Major goals in maxillofacial fracture treatment include to restore the dental occlusion, stabilise the major skeletal supports, restore the…”
Get full text

Randomized trial of anesthetic methods for intravitreal injections by Blaha, Gregory R, Tilton, Elisha P, Barouch, Fina C, Marx, Jeffrey L

“…To compare the effectiveness of four different anesthetic methods for intravitreal injection. Twenty-four patients each received four intravitreal injections…”
Get full text

Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs by Ramsey, David J, Poulin, Samuel J, LaMonica, Lauren C, Blaha, Gregory R, Barouch, Fina C, Chang, Jeffrey, Marx, Jeffrey L

“…To evaluate the functional and anatomic outcomes, as well as cost-effectiveness, of the timing of conversion to intravitreal aflibercept (IVA) in patients with…”
Get full text

Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medications by Blaha, Gregory R, Brooks, Nneka O, Mackel, Charles E, Pani, Altin, Stewart, Avon P, Price, Lori L, Barouch, Fina C, Chang, Jeffrey, Marx, Jeffrey L

“…To compare the change in anterior chamber flare after intravitreal injection of the anti-vascular endothelial growth factor agents bevacizumab, aflibercept,…”
Get full text

Benefits of a Homecare Integral Patient Support Program in Idiopathic Pulmonary Fibrosis by Cobo Sanchez, L., Ruiz Herrero, C., Cobos, I., Bespin, J., Gadea, C., Cerdá-Cortés, P., Palma, J., Vicens-Zygmunt, V., Bermudo, G., Portillo, K., Boldova, A., Robles, A., Arribas, J., Figuerola, J.A., Blavia, R., Moreno, A., Castillo, D., Villar, A., Belmonte, Y., Badenes-Bonet, D., Zayas, D., Suarez-Cuartin, G., Garcia-Bellmunt, L., Sellarés, J., Barril, S., Sans, J., Serra, M., Perich, D., Esteban, L.L., Esteban, L., Balcells, E., Gil, F., Ruiz, E., Fina, C., Molina-Molina, Maria

Get full text

Prophylactic Use of Laser Light and Methylene Blue on Ischemia and Liver Reperfusion Injury by Albuquerque, F.P., Laureano, E., Jordani-Gomes, M.C., Fina, C.F., Vanni, C., Mente, E.D., Vollet Filho, J.D., Bagnato, V.S., Dálbuquerque, L.A.C., Évora, P.R.B., Castro e Silva, O.

“…This study aimed to evaluate the effect of hepatic preconditioning with laser light in the presence of methylene blue (MB) in the liver ischemia-reperfusion…”
Get full text

Should Preconditioning Hyperbaric Oxygenation Protect the Liver Against Ischemia–Reperfusion Injury? An Experimental Study in a Rat Model by Losada, D.M, Jordani, M.E, Jordani, M.C, Piccinato, M.A.N.C, Fina, C.F, Feres, O, Chies, A.B, Evora, P.R.B, de Castro e Silva, O

“…Abstract Objectives We designed studies to test the hypotheses that hyperbaric oxygen (HBO) therapy should protect liver against subsequent…”
Get full text

Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration by Barouch, Fina C, Miller, Joan W

Get full text

The role of inflammation and infection in age-related macular degeneration by Barouch, Fina C, Miller, Joan W

Get full text

Intraperitoneal immunity and pneumoperitoneum by CHEKAN, E. G, NATARAJ, C, CLARY, E. M, HAYWARD, T. Z, BRODY, F. J, STAMAT, J. C, FINA, M. C, EUBANKS, W. S, WESTCOTT, C. J

“…Carbon dioxide (CO(2)) pneumoperitoneum has been implicated as a possible factor in depressed intraperitoneal immunity. Using in vitro functional assays, CO(2)…”
Get full text

Liver Mitochondrial Function in Familial Amyloidotic Polyneuropathy by Castro e Silva, O, Sankarankutty, A.K, Souza, M.E.J, Picinato, M.A.N.C, Fina, C.F, Jordani, M.C, Mente, E.D, Cagnolatti, D, Teixeira, A.C, Souza, F.F, Martinelli, A.L.C, Rondon, L.Z

“…Abstract The objective of the present study was to analyze hepatic mitochondrial function in patients with familial amyloidotic polyneuropathy (FAP) undergoing…”
Get full text

Potential future targets for treating ocular neovascularization by Barouch, Fina C, Miller, Joan W

“…A wide variety of mediators likely contribute to ocular NV and these can serve as potential targets for the treatment of ocular NV. Several targets have…”
Get more information

429 (PB417): Lessons learned from a pan-cancer exploratory Liquid Biopsy (LB) profiling: the PREICO-LB project by Hierro, C., Notario, L., Bergamino, M., Sabat, P., Soto-Castillo, J.J., Calvo, M., Oliva, M., Jove, M., Ruffinelli, J.C., Mosteiro, M.A., de Olza, M. Ochoa, Carcereny, E., Balaña, D., Gonzalez, M.I., Fina, C., Gil-Martin, M., Nadal, E., Azuara, D., Lazaro, C., Martin-Liberal, J.

Get full text

1272P First results of the early onset lung cancer (EOLUNG) study to characterize genomic alterations using FoundationOne CDx in young patients with non-small cell lung cancer by Casulleras, M. Jove, Barrera, J. Bosch, Sais, E., Hernandez, A., Gasusachs, M., Carcereny, E., Moran, T., Vinolas, M. Domenech, Palmero, R., Brenes, J., Vilariño, N., Ruffinelli, J.C.C., Fina, C., Lorente, S., Teule, A., Lazaro, C., Nadal, E.

Get full text

A canine model of gastroesophageal reflux disease (GERD) by MCMAHON, R. L, ALI, A, EUBANKS, W. S, CHEKAN, E. G, CLARY, E. M, GARCIA-ORIA, M. J, FINA, M. C, MCRAE, R. L, KO, A, GANDSAS, A, PAPPAS, T. N

“…Although a variety of antireflux procedures and medications are used to treat gastroesophageal reflux disease (GERD), reliable large-animal models of GERD that…”
Get full text

748P Real-world-data (RWD) on platinum (Pt)-based chemotherapy (CT) after PARP inhibitors (PARPi) in high-grade serous (or endometrioid) ovarian cancer (HGSEOC) by Romeo Marin, M., Gil-Martin, M., Gaba Garcia, L., Fina, C., Taus, Á., Murata, P., Masvidal, M., Martinez, A., Fernández-Plana, J., García, Y., Pérez, C., Cros Costa, S., Rodriguez, V., Zanui, M., Catot, S., Plaja, A., Teruel, I., Pardo Búrdalo, B., Barretina-Ginesta, M-P., Esteve, A.M.

Get full text

655P Prognostic significance of docetaxel (D) plus androgen-deprivation therapy (ADT) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) according to extent of disease: A study of real-world data by Notario, L., Piulats, J.M., Sala, N., Ferrándiz, U., González, A., Etxániz, O., Villà, S., Buisan, O., Boladeras, A., Heras, L., Del Carpio, L., Roselló, A., Barretina, P., Fina, C., Pardo, J.C., Suárez, J.M., Comet, J., Garcia del Muro, X., Esteve, A., Font, A.

Get full text

667P Impact of pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) on overall survival (OS) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) treated with docetaxel (D) plus androgen-deprivation therapy (ADT) by Notario, L., Piulats, J.M., Sala, N., Ferrandiz, U., González, A., Etxániz, O., Heras, L., Buisan, O., Del Carpio, L., Álvarez, A., Boladeras, A., Roselló, A., Barretina, P., Fina, C., Pardo, J.C., Suárez, J.M., Comet, J., Garcia del Muro, X., Esteve, A., Font, A.

Get full text

1021PThe prognostic impact of monocyte to lymphocyte ratio (MLR) in advanced epithelial ovarian cancer (EOC) by Salamero, M Cucurull, García, I Teruel, Arroyo, A J, Pardo, B, Gil, M, Piulats, J M, Pla, H, Fina, C, Ginesta, M P Barretina, Angelats, L, Falgas, E Felip, Lecuona, C Erasun, Mosquera, J J García, Román, S Martinez, Carballas, E, Hernandez, J, Esteve, A, Romeo, M

“…Abstract Background Among the inflammation-related biomarkers, high MLR values are associated to poorer outcomes in different cancers. We explored the…”
Get full text